ImmunityBio, Inc. - Common Stock — 현금 흐름 (NASDAQ:IBRX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -70.45 M-274.42 M-337.51 M-366.76 M-391.24 M-304.94 M -294.39 M 투자 활동으로 인한 현금 -20.59 M-84.89 M27.3 M-30.47 M-12.25 M-149.8 M -185.58 M 재무활동으로 인한 현금 86.97 M505.44 M233.61 M558.34 M281.63 M400.24 M 625.15 M 잉여 현금 흐름 -70.45 M-274.42 M-337.51 M-366.76 M-391.24 M-309.19 M -298.9 M

뉴스

IBRX and the BCG Shortage: Deals That Could Expand Demand

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

Undercovered Stocks: Cerebras Systems, Infleqtion, Duos Technologies And More

FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy

ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

Why ImmunityBio Stock Is Surging On Wednesday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts

Is IBRX Priced for Perfection at Nearly 28x Forward Sales?